Quick Dispatch:
Your foxo4-dri senolytic 2024 study Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: JACC Family Series orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your foxo4-dri senolytic 2024 study Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: JACC Family Series ships.
Need Help?
Questions about foxo4-dri senolytic 2024 study Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: JACC Family Series, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for foxo4-dri senolytic 2024 study Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: JACC Family Series in your area.
Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis
28.19
FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation
22.45
FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells
25.03
FOXO4-DRI
27.06
FOXO4-DRI causes nuclear exclusion of active p53 and induces apoptosis
29.15
foxo4-dri human clinical trial FOXO4-DRI 10mg Research Peptide
29.53
foxo4-dri senolytic 2024 Buy Wholesale Price Fox04-Dri Foxo4 Dri Peptide Foxo4-Dri Powder CAS: 2460055-10-9 in Stock Pharmaceutical Grade from QIngdao Sigma Chemical Co.,Ltd
29.33
